GRACEcast ALL Subjects audio and video
Highlights in Lung Cancer, 2013: MEK Inhibitors for KRAS Mutation-Positive NSCLC (audio)
- Autor: Podcast
- Narrador: Podcast
- Editor: Podcast
- Duración: 0:05:27
- Mas informaciones
Informações:
Sinopsis
Dr. Natasha Leighl, Princess Margaret Hospital in Toronto, Canada, reviews exciting new data illustrating the potential benefits of the MEK inhibitor selumetinib in treating KRAS mutation-positive advanced non-small cell lung cancer.
